Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. [electronic resource]
Producer: 20111121Description: 867-79 p. digitalISSN:- 1432-2277
- Adrenal Cortex Hormones -- adverse effects
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bone Density
- Bone Diseases, Metabolic -- etiology
- Calcium, Dietary -- therapeutic use
- Child
- Denosumab
- Diphosphonates -- therapeutic use
- Graft vs Host Disease -- complications
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hormone Replacement Therapy
- Humans
- Magnetic Resonance Imaging
- Osteonecrosis -- diagnosis
- Osteoporosis -- diagnosis
- Parathyroid Hormone -- analogs & derivatives
- RANK Ligand -- therapeutic use
- Risk Factors
- Selective Estrogen Receptor Modulators -- therapeutic use
- Vitamin D -- therapeutic use
No physical items for this record
Publication Type: Consensus Development Conference; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.